May 11, 2026 08:30AM
Apr 2, 2026 07:28AM
Feb 24, 2026 12:35AM
Jan 13, 2026 01:58PM
Jan 12, 2026 12:36PM
Jan 8, 2026 11:19AM
Oct 9, 2025 06:02AM Novo Nordisk to acquire Akero Therapeutics for up to $5.2 billion
Feb 6, 2025 02:13AM
Dec 18, 2024 08:57AM
Dec 6, 2024 01:08PM
Nov 11, 2024 02:21AM
Sep 27, 2024 08:00AM
Sep 5, 2024 02:31AM
Jul 11, 2024 06:53AM Pfizer moves forward with once-daily weight-loss pill
Jul 3, 2024 07:43AM
May 24, 2024 11:04AM
Mar 25, 2024 11:38AM
Feb 5, 2024 08:03AM
Feb 5, 2024 06:23AM
Feb 5, 2024 06:00AM
Jan 31, 2024 07:08AM As Lilly rivalry flares, Novo CEO sets out Wegovy launch strategy
Jan 11, 2024 06:29AM
Dec 12, 2023 11:43AM
Aug 31, 2023 12:29PM
May 29, 2019 05:46AM
May 7, 2019 01:27AM
Jan 2, 2019 03:13AM
Nov 19, 2018 04:39AM JPMorgan Upgrades Novo Nordisk (NOVOB:DC) (NVO) to Overweight
Oct 4, 2018 09:51AM
Jan 29, 2018 05:32AM
Jan 8, 2018 07:28AM
Jan 8, 2018 07:26AM
Jan 8, 2018 07:25AM
Dec 29, 2017 05:47AM
Mar 2, 2017 01:21PM Form F-6 POS NOVO NORDISK A S Filed by: JPMorgan Chase Bank, N.A. - ADR Depositary
Jan 3, 2017 11:51AM
Sep 9, 2016 03:27PM
Sep 9, 2016 08:05AM
Sep 2, 2016 10:23AM
May 14, 2014 10:52AM
Feb 24, 2014 11:48AM
Mar 18, 2013 10:56AM Notable Analyst Rating Changes 03/18: (ODP) (VZ) (GLUU) Upgraded; (NVO) (CCL) (CNP) Downgraded
Mar 18, 2013 07:50AM
Mar 14, 2013 05:49PM
Feb 11, 2013 09:41AM
Apr 11, 2011 07:55AM
Sep 11, 2009 10:31AM
Aug 7, 2009 07:44AM
Jun 26, 2009 01:58PM Analysts Downgrade Sanofi Aventis Amid Long-Acting Insulin Concerns; Amylin Benefiting (SNY, AMLN, NVO)
Apr 6, 2009 10:29AM

287,613 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All